303 related articles for article (PubMed ID: 12015517)
41. Pelvic inflammatory disease.
Gradison M
Am Fam Physician; 2012 Apr; 85(8):791-6. PubMed ID: 22534388
[TBL] [Abstract][Full Text] [Related]
42. Comparison of ceftizoxime versus combination therapy in the treatment of pelvic inflammatory disease (PID).
Wikler MA; Moonsammy GI; Hemsell DL
J Chemother; 1989 Jul; 1(4 Suppl):882-3. PubMed ID: 16312685
[No Abstract] [Full Text] [Related]
43. Single-agent therapy for acute pelvic inflammatory disease: sulbactam/ampicillin versus cefoxitin.
Hemsell DL; Bawdon RE; Hemsell PG; Nobles BJ; Heard MC
J Int Med Res; 1990; 18 Suppl 4():85D-89D. PubMed ID: 2282973
[TBL] [Abstract][Full Text] [Related]
44. Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis.
Mugo NR; Kiehlbauch JA; Nguti R; Meier A; Gichuhi JW; Stamm WE; Cohen CR
Obstet Gynecol; 2006 Apr; 107(4):807-12. PubMed ID: 16582116
[TBL] [Abstract][Full Text] [Related]
45. Pelvic inflammatory disease.
Wølner-Hanssen P
Curr Opin Obstet Gynecol; 1991 Oct; 3(5):687-91. PubMed ID: 1835659
[TBL] [Abstract][Full Text] [Related]
46. Compliance with doxycycline therapy for outpatient treatment of pelvic inflammatory disease.
Brookoff D
South Med J; 1994 Nov; 87(11):1088-91. PubMed ID: 7973890
[TBL] [Abstract][Full Text] [Related]
47. Outpatient management of pelvic inflammatory disease.
Price B; Martens M
Curr Womens Health Rep; 2001 Aug; 1(1):36-40. PubMed ID: 12112950
[TBL] [Abstract][Full Text] [Related]
48. Pelvic inflammatory disease: new diagnostic criteria and treatment.
Beigi RH; Wiesenfeld HC
Obstet Gynecol Clin North Am; 2003 Dec; 30(4):777-93. PubMed ID: 14719850
[TBL] [Abstract][Full Text] [Related]
49. Results of a randomized, multicenter, comparative trial of a single dose of cefotetan versus multiple doses of cefoxitin as prophylaxis in cesarean section.
McGregor JA; Gordon SF; Krotec J; Poindexter AN
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):701-6. PubMed ID: 3281461
[TBL] [Abstract][Full Text] [Related]
50. Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease.
Landers DV; Wolner-Hanssen P; Paavonen J; Thorpe E; Kiviat N; Ohm-Smith M; Green JR; Schachter J; Holmes KK; Eschenbach DA
Am J Obstet Gynecol; 1991 Mar; 164(3):849-58. PubMed ID: 1900663
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of intravenous azithromycin followed by oral azithromycin for the treatment of acute pelvic inflammatory disease and perihepatitis in Japanese women.
Mikamo H; Iwasaku K; Yamagishi Y; Matsumizu M; Nagashima M
J Infect Chemother; 2014 Jul; 20(7):429-35. PubMed ID: 24787738
[TBL] [Abstract][Full Text] [Related]
52. A comparative study of injection placentrex and conventional therapy in treatment of pelvic inflammatory disease.
Garg R; Zahra F; Chandra JA; Vatsal P
J Indian Med Assoc; 2008 Jul; 106(7):463, 467. PubMed ID: 18975504
[TBL] [Abstract][Full Text] [Related]
53. Pelvic inflammatory disease.
Peterson HB; Galaid EI; Cates W
Med Clin North Am; 1990 Nov; 74(6):1603-15. PubMed ID: 2246955
[TBL] [Abstract][Full Text] [Related]
54. Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial.
Malhotra M; Sharma JB; Batra S; Arora R; Sharma S
Indian J Med Sci; 2003 Dec; 57(12):549-55. PubMed ID: 14701947
[TBL] [Abstract][Full Text] [Related]
55. Pelvic inflammatory disease: a contemporary approach.
Newkirk GR
Am Fam Physician; 1996 Mar; 53(4):1127-35. PubMed ID: 8629562
[TBL] [Abstract][Full Text] [Related]
56. A review of antibiotic therapy for pelvic inflammatory disease.
Duarte R; Fuhrich D; Ross JD
Int J Antimicrob Agents; 2015 Sep; 46(3):272-7. PubMed ID: 26126798
[TBL] [Abstract][Full Text] [Related]
57. Pelvic inflammatory disease: review of treatment options.
Peterson HB; Galaid EI; Zenilman JM
Rev Infect Dis; 1990; 12 Suppl 6():S656-64. PubMed ID: 2201077
[TBL] [Abstract][Full Text] [Related]
58. Sulbactam/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory disease.
Hemsell DL; Heard MC; Hemsell PG; Nobles BJ
Drugs; 1988; 35 Suppl 7():39-42. PubMed ID: 3220008
[TBL] [Abstract][Full Text] [Related]
59. Acute pelvic inflammatory disease: follow-up in laparoscopically confirmed cases.
Spirtos NJ; Bernstine RL; Cossler N
J Am Osteopath Assoc; 1983 Dec; 83(4):297-300. PubMed ID: 6230340
[TBL] [Abstract][Full Text] [Related]
60. 2017 European guideline for the management of pelvic inflammatory disease.
Ross J; Guaschino S; Cusini M; Jensen J
Int J STD AIDS; 2018 Feb; 29(2):108-114. PubMed ID: 29198181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
